SCOPUS 정보 검색 플랫폼

Journal of Pediatrics

Volumn 137, Issue 2, 2000, Pages 192-196

Use of infliximab in the treatment of Crohn's disease in children and adolescents

(3) Hyams, Jeffrey S a,b,c,d,e Markowitz, James a,b,c,d,e Wyllie, Robert a,b,c,d,e

a Farmington (United States)

b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE (United States)

c North Shore Long Island Jewish Health System ^* (United States)

d University School of Medicine (United States)

e LERNER RESEARCH INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT DISEASE; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CROHN DISEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0033842357 PISSN: 00223476 EISSN: None Source Type: Journal
DOI: 10.1067/mpd.2000.107161 Document Type: Article

Times cited : (142)

References (26)

1
- 0028236232
- Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease
- (1994) Gastroenterology , vol.106 , pp. 1455-1466
- Breese, E.J.¹ Michie, C.A.² Nicholls, S.W.³ Murch, S.H.⁴ Williams, C.B.⁵ Domizio, P.⁶

2
- 0027451455
- Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1-beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
- (1993) Clin Exp Immunol , vol.94 , pp. 174-181
- Reinecker, H.C.¹ Steffen, M.² Witthoeft, T.³ Pflueger, I.⁴ Schreiber, S.⁵ MacDermott, R.P.⁶

3
- 0026531017
- Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
- (1992) Lancet , vol.339 , pp. 89-91
- Braegger, C.P.¹ Nichols, S.² Murch, S.H.³ Stephens, S.⁴ MacDonald, T.T.⁵

4
- 0029004771
- Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions
- (1995) Cytokine , vol.7 , pp. 251-259
- Scallon, B.J.¹ Moore, M.A.² Trinh, H.³ Knight, D.M.⁴ Ghrayeb, J.⁵

5
- 0028964310
- The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo
- (1995) Cytokine , vol.7 , pp. 15-25
- Siegel, S.A.¹ Shealy, D.J.² Nakada, M.T.³ Le, J.⁴ Woulfe, D.S.⁵ Probert, L.⁶

6
- 0029050742
- Treatment of Crohn's disease with anti-tumour necrosis chimeric monoclonal antibody (cA2)
- (1995) Gastroenterology , vol.109 , pp. 129-135
- Van Dullemen, H.M.¹ Van Deventer, S.J.H.² Hommes, D.W.³ Bijl, H.A.⁴ Jansen, J.⁵ Tytgat, N.J.⁶

7
- 0030954732
- A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
- (1997) N Engl J Med , vol.337 , pp. 1029-1035
- Targan, S.R.¹ Hanauer, S.B.² Van Deventer, S.J.H.³ Mayer, L.⁴ Present, D.H.⁵ Braakman, T.⁶

8
- 0032913394
- Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
- (1999) Gastroenterology , vol.116 , pp. 1029-1034
- D'Haens, G.¹ Van Deventer, S.² Van Hogezand, R.³ Chalmers, D.⁴ Kothe, C.⁵ Baert, F.⁶

9
- 0032923705
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
- (1999) Gastroenterology , vol.116 , pp. 22-28
- Baert, F.J.¹ D'Haens, G.² Peeters, M.³ Hiele, M.I.⁴ Schaible, T.F.⁵ Shealy, D.⁶

10
- 0000840957
- A multicenter study of infliximab (anti-TNF α antibody) in the treatment of children with active Crohn's disease
- (1999) Gastroenterology , vol.116
- Baldassano, R.¹ Vasiliauskis, E.² Braegger, C.P.³ Escher, J.C.⁴ Sinaasappel, M.⁵ Wagner, C.⁶

11
- 0000994947
- Treatment of pediatric Crohn's disease (CD) with anti-tumor necrosis factor alpha chimeric monoclonal antibody (infliximab)
- (1999) Gastroenterology , vol.116
- Kugathansan, S.¹ Rivera, M.T.² Martinez, A.³ Binion, D.G.⁴ Werlin, S.L.⁵

12
- 4243653850
- Collaborative experience of open-label anti-TNF alpha chimeric monoclonal antibody, Remicade, in pediatric patients with refractory Crohn's disease
- (1999) Gastroenterology , vol.116
- Vasiliauskas, E.A.¹ Thomas, D.W.² Schaffer, S.³ Marshall, W.F.⁴ Targan, S.R.⁵

13
- 0025796809
- Development and validation of a Pediatric Crohn's Disease Activity Index
- (1991) J Pediatr Gastroenterol Nutr , vol.12 , pp. 439-447
- Hyams, J.S.¹ Ferry, G.D.² Mandel, F.S.³ Gryboski, J.D.⁴ Kibort, P.M.⁵ Kirschner, B.S.⁶

14
- 0033529049
- Infliximab for the treatment of fistulas in patients with Crohn's disease
- (1999) N Engl J Med , vol.340 , pp. 1398-1405
- Present, D.H.¹ Rutgeerts, P.² Targan, S.³ Hanauer, S.B.⁴ Mayer, L.⁵ Van Hogezand⁶

15
- 0031425159
- Immunomodulation of Crohn's disease using TNF-α neutralizing monoclonal antibodies
- (1997) Clin Nutr , vol.16 , pp. 271-275
- Van Deventer, S.J.H.¹

16
- 0028244816
- Tumor necrosis factor: A pleiotropic cytokine and therapeutic target
- (1994) Ann Rev Med , vol.45 , pp. 491-503
- Tracey, K.J.¹ Cerami, A.²

17
- 0030981088
- Tumour necrosis factor and Crohn's disease
- (1997) Gut , vol.40 , pp. 443-448
- Van Deventer, S.J.H.¹

18
- 0030749419
- Tumour necrosis factor and inflammatory bowel disease
- (1997) Br J Surg , vol.84 , pp. 1051-1058
- Armstrong, A.M.¹ Gardiner, K.R.² Kirk, S.J.³ Halliday, M.I.⁴ Rowlands, B.J.⁵

19
- 0031005155
- Mediators of mucosal inflammation: Implications for therapy
- (1997) Scand J Gastroenterol , vol.32 , Issue.SUPPL. 223 , pp. 92-98
- Van Dullemen, H.¹ Meenan, J.² Stronkhorst, A.³ Tytgat, G.N.J.⁴ Van Deventer, S.J.H.⁵

20
- 0027935309
- Leukocyte-endothelial adhesion molecules
- (1994) Blood , vol.84 , pp. 2068-2101
- Carlos, T.M.¹ Harlan, J.M.²

21
- 0028830960
- Regulatory roles of tumor necrosis factor alpha and interleukin 1 beta in monocyte chemoattractant protein 1 mediated pulmonary granuloma formation in the rat
- (1995) Am J Pathol , vol.146 , pp. 450-462
- Flory, C.M.¹ Jones, M.L.² Miller, B.F.³ Warren, J.S.⁴

22
- 0342530626
- Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response
- (1989) Proc Natl Acad Sci USA , vol.86 , pp. 4220-4224
- LoBuglio, A.F.¹ Wheeler, R.H.² Trang, J.³ Haynes, A.⁴ Rogers, K.⁵ Harvey, E.B.⁶

23
- 0028143212
- Repeated therapy with monoclonal antibody to tumor necrosis factor α (cA2) in patients with rheumatoid arthritis
- (1994) Lancet , vol.344 , pp. 1125-1127
- Elliott, M.J.¹ Maini, R.N.² Feldmann, M.³ Long-Tox, A.⁴ Charles, P.⁵ Bijl, H.⁶

24
- 0031660364
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
- (1998) Arthritis Rheum , vol.41 , pp. 1552-1563
- Maini, R.N.¹ Breedveld, F.C.² Kalden, J.R.³ Smolen, J.S.⁴ Davis, D.⁵ Macfarlane, J.D.⁶

25
- 0032543858
- Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study
- (1998) Br Med J , vol.317 , pp. 180-181
- Baecklund, E.¹ Ekbom, A.² Sparen, P.³ Feltelius, N.⁴ Klareskog, L.⁵

26
- 0032833517
- Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
- (1999) Gastroenterology , vol.117 , pp. 761-769
- Rutgeerts, P.¹ D'Haens, G.² Targan, S.³ Vasiliauskas, E.⁴ Hanauer, S.B.⁵ Present, D.H.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.